|
1
|
Adams TS, Maluleke JC and Cuello MA:
Cancer of the vagina: 2025 update. Int J Gynaecol Obstet. 171
(Suppl 1):S48–S59. 2025. View Article : Google Scholar
|
|
2
|
Rajaram S, Maheshwari A and Srivastava A:
Staging for vaginal cancer. Best Pract Res Clin Obstet Gynaecol.
29:822–832. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kulkarni A, Dogra N and Zigras T:
Innovations in the management of vaginal cancer. Curr Oncol.
29:3082–3092. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Frank SJ, Deavers MT, Jhingran A, Bodurka
DC and Eifel PJ: Primary adenocarcinoma of the vagina not
associated with diethylstilbestrol (DES) exposure. Gynecol Oncol.
105:470–474. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
White MC, Weir HK, Soman AV, Peipins LA
and Thompson TD: Risk of clear-cell adenocarcinoma of the vagina
and cervix among US women with potential exposure to
diethylstilbestrol in utero. Cancer Causes Control. 33:1121–1124.
2022.PubMed/NCBI
|
|
6
|
National Cancer, Institute (NCI), .
Diethylstilbestrol (DES) exposure and cancer. National Institutes
of Health; Bethesda, MD: 2025
|
|
7
|
Smith EK, White MC, Weir HK, Peipins LA
and Thompson TD: Higher incidence of clear cell adenocarcinoma of
the cervix and vagina among women born between 1947 and 1971 in the
United States. Cancer Causes Control. 23:207–211. 2012.PubMed/NCBI
|
|
8
|
Hong MK and Ding DC: Vaginal
adenocarcinoma: A review of a rare gynecologic cancer. Cancers
(Basel). 17:21302025. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Van der Aa MA, Helmerhorst TJM, Siesling
S, Riemersma S and Coebergh JW: Vaginal and (uncommon) cervical
cancers in the Netherlands, 1989–2003. Int J Gynecol Cancer.
20:638–645. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chan JKC: The wonderful colors of the
hematoxylin-eosin stain in diagnostic surgical pathology. Int J
Surg Pathol. 22:12–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nayar R and Wilbur DC: The Pap test and
Bethesda 2014. Cancer Cytopathol. 123:271–281. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
FIGO Committee on Gynecologic Oncology, .
Current FIGO staging for cancer of the vagina, fallopian tube,
ovary, and gestational trophoblastic neoplasia. Int J Gynaecol
Obstet. 105:3–4. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The Eighth Edition AJCC Cancer Staging Manual:
Continuing to build a bridge from a population-based to a more
“personalized” approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017.PubMed/NCBI
|
|
14
|
Yang J, Delara R, Magrina J, Magtibay P,
Langstraat C, Dinh T, Karlin N, Vora SA and Butler K: Management
and outcomes of primary vaginal cancer. Gynecol Oncol. 159:456–463.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alfonzo E, Holmberg ECV, Sparén P, Milsom
I and Strander B: Risk of vaginal cancer among hysterectomised
women with cervical intraepithelial neoplasia: A population-based
national cohort study. BJOG. 127:448–454. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qian J, Gracious K, Chen L and Xu S:
Primary vaginal cancer after hysterectomy for benign conditions: A
systematic review of the literature. Front Oncol. 14:13347782024.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barnard ME, Farland LV, Yan B, Wang J,
Trabert B, Doherty JA, Meeks HD, Madsen M, Guinto E, Collin LJ, et
al: Endometriosis typology and ovarian cancer risk. JAMA.
332:482–489. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim H, Kim HJ and Ahn HS: Does
endometriosis increase the risks of endometrial hyperplasia and
endometrial cancer? Gynecol Oncol. 169:147–153. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Etrusco A, Barra F, Chiantera F, Ferrero
S, Bogliolo S, Evangelisti G, Oral E, Pastore M, Izzotti A, Venezia
R, et al: Current medical therapy for adenomyosis: From bench to
bedside. Drugs. 83:1595–1611. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang P, Song K, Li L, Yukuwa K and Kong
B: Efficacy of combined levonorgestrel-releasing intrauterine
system with gonadotropin-releasing hormone analog for the treatment
of adenomyosis. Med Princ Pract. 22:480–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee KH, Kim JK, Lee MA, Ko YB, Yang JB,
Kang BH and Yoo HJ: Relationship between uterine volume and
discontinuation of treatment with levonorgestrel-releasing
intrauterine devices in patients with adenomyosis. Arch Gynecol
Obstet. 294:561–566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kyei-Barffour I, Margetts M, Vash-Margita
A and Pelosi E: The embryological landscape of
Mayer-Rokitansky-Kuster-Hauser Syndrome: Genetics and environmental
factors. Yale J Biol Med. 94:657–672. 2021.PubMed/NCBI
|
|
23
|
Bhamidipaty-Pelosi S, Kyei-Barffour I,
Volpert M, O'Neill N, Grimshaw A, Eriksson L, Vash-Margita A and
Pelosi E: Müllerian anomalies and endometriosis: Associations and
phenotypic variations. Reprod Biol Endocrinol. 22:1572024.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Manfredi GI, Dicitore A, Gaudenzi G,
Caraglia M, Persani L and Vitale G: PI3K/Akt/mTOR signaling in
medullary thyroid cancer: A promising molecular target for cancer
therapy. Endocrine. 48:363–370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hendricks LAJ, Verbeek KCJ,
Schuurs-Hoeijmakers JHM, Jong MM, Links TP, Brems H, Aerden M,
Brunet J, Lleuger-Pujol R, Hüneburg R, et al: The risk of a second
primary cancer in PTEN hamartoma tumor syndrome (PHTS). Genet Med.
27:1014672025. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ramírez-Moya J, Wert-Lamas L and
Santisteban P: MicroRNA-146b promotes PI3K/AKT pathway
hyperactivation and thyroid cancer progression by targeting PTEN.
Oncogene. 37:3369–3383. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nero C, Ciccarone F, Pietragalla A and
Scambia G: PTEN and gynecological cancers. Cancers (Basel).
11:14582019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hendricks LJ, Hoogerbrugge N, Mensenkamp
AR, Brunet J, Lleuger-Pujol R, Høberg-Vetti H, Tveit Haavind M,
Innella G, Turchetti D, Aretz S, et al: Cancer risks by sex and
variant type in PTEN hamartoma tumor syndrome. J Natl Cancer Inst.
115:93–103. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Staats PN, Clement PB and Young RH:
Primary endometrioid adenocarcinoma of the vagina: A
clinicopathologic study of 18 cases. Am J Surg Pathol.
31:1490–1501. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ugwu AO, Haruna M, Okunade KS, Ohazurike
E, Anorlu RI and Banjo AAF: Primary vaginal adenocarcinoma of
intestinal-type: Case report of a rare gynaecological tumour. Oxf
Med Case Reports. 2019:omz0882019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Westerveld H, Nesvacil N, Fokdal L,
Chargari C, Schmid MP, Milosevic M, Mahantshetty UM and Nout RA:
Definitive radiotherapy with image-guided adaptive brachytherapy
for primary vaginal cancer. Lancet Oncol. 21:e157–e167. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
ACOG practice bulletin No 109, . Cervical
cytology screening. Obstet Gynecol. 114:1409–1420. 2009. View Article : Google Scholar : PubMed/NCBI
|
